For example, the endogenous kallikrein inhibitor, kallistatin, was reduced in the crypt epithelium and increased in the lamina propria in biopsies from individuals with IBD (Devani et al., 2005). This evidence concerns the gene SERPINA4 and inflammatory bowel disease.